Literature DB >> 7032632

Prostaglandins release plasma 'reciprocal coupling factor' in anaesthetized rats.

J R Hoult, P K Moore.   

Abstract

1. Prostaglandins E1, E2, I2 and endoperoxide analogue U46619 injected intra-arterially (i.a.) into anaesthetized rats at 2 micrograms/kg caused a substantial increase within 60 min of the plasma activity of prostaglandin 'reciprocal coupling factor' (RCF). RCF is the provisional name for the component(s) of plasma which inhibit microsomal prostaglandin synthesis and enhance cytosolic prostaglandin breakdown. 2. RCF is not released by inactive metabolite 13,14-dihydro-15-keto prostaglandin E2 (10 micrograms/kg, i.a.) or acetylcholine or histamine (2 micrograms/kg, i.a.). 3. We suggest that release by prostaglandins of RCF would provide the basis in vivo for a negative feedback mechanism controlling the activity of the prostaglandin system.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7032632      PMCID: PMC2071719          DOI: 10.1111/j.1476-5381.1981.tb09994.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  3 in total

1.  Some biological effects of prostaglandin endoperoxide analogs.

Authors:  C Malmsten
Journal:  Life Sci       Date:  1976-01-15       Impact factor: 5.037

2.  Human plasma contains prostaglandin 'reciprocal coupling factor'.

Authors:  P G Hellewell; C N Berry; P K Moore; J R Hoult
Journal:  Eur J Pharmacol       Date:  1980-12-19       Impact factor: 4.432

3.  Pathophysiological states modify levels in rat plasma of factors which inhibit synthesis and enhance breakdown of PG.

Authors:  P K Moore; J R Hoult
Journal:  Nature       Date:  1980-11-20       Impact factor: 49.962

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.